By A Mystery Man Writer
SEC Filing ProQR Therapeutics
EX-99.1
SEC Filing AN2 Therapeutics, Inc
S-1
A brief history of human disease genetics
tbio-10k_20181231.htm
Frontiers Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
Translate Bio : 2020 NACFC Oral Presentation -October 21, 2020 at 11:00 am EDT
Frontiers Translational Research in Cystic Fibrosis: From Bench to Beside
Endpoints News — Inside the triumph and failure of Sage's new postpartum drug; Merck to pursue GLP-1 combos
Sequencing as a first-line methodology for cystic fibrosis carrier screening
Discovery of the Cystic Fibrosis Gene, RI History
arct-10k_20181231.htm
DRS